Assessment of immunosuppression induction with basiliximab compared to antithymocyte‐globulin in adult heart transplant patients

Documenti analoghi

• A heart transplant center experience with basiliximab induction strategies: A double edged sword?
  di: Luise Holzhauser, et al.
  Pubblicazione: (2024)
• Outcomes of older Black renal transplant recipients receiving basiliximab induction and early steroid withdrawal
  di: Sarah E Bova, et al.
  Pubblicazione: (2024)
• Alemtuzumab versus anti‐thymocyte globulin in kidney transplant recipients receiving a rapid steroid withdrawal regimen
  di: Rachel A. Rikard, et al.
  Pubblicazione: (2024)
• Long‐term outcomes for pediatric heart transplant recipients transitioning to adult care teams
  di: Elena M. Donald, et al.
  Pubblicazione: (2024)
• Effects of WuZhi preparations on tacrolimus in pediatric and adult patients carrying the CYP3A5*1 allele of heart transplant during the early period after transplantation
  di: Li Liu, et al.
  Pubblicazione: (2024)